your catalyst to a lucrative business n.
Download
Skip this Video
Loading SlideShow in 5 Seconds..
China Bioprocess Instruments Industry Research Report PowerPoint Presentation
Download Presentation
China Bioprocess Instruments Industry Research Report

Loading in 2 Seconds...

play fullscreen
1 / 6

China Bioprocess Instruments Industry Research Report - PowerPoint PPT Presentation


  • 3 Views
  • Uploaded on

The China bioprocess instruments market size was estimated at USD 1.18 billion in 2016 and is expected to grow on account of the evolution of new technologies.

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

China Bioprocess Instruments Industry Research Report


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
your catalyst to a lucrative business

Your Catalyst To a Lucrative Business

China Bioprocess Instruments Market Size, Share, Growth,

Analysis and Forecast to 2024 - Hexa Research

“China bioprocess instruments market is expected to

reach USD 3.06 billion by 2024 owing to the improving

economy, rising aging population and increasing

prevalence of chronic diseases.”

The China Bioprocess Instruments Market is expected to reach USD 3.06 billion by 2024 owing to the

improving economy, rising aging population and increasing prevalence of chronic diseases. Moreover,

increasing demand for single-use instruments in disposable applications is anticipated to augment the growth

over the projected period.

China was the second largest pharmaceutical market in the world, expected to grow USD 173 billion by 2024,

growing at a CAGR of 9.1% owing to the requirement of medication & drugs to cure deadly diseases. Huge

investment in biotechnology will primarily drive the growth of the market, as pharma companies deal in

innovations for developing medicines and drugs in line with the increasing prevalence of diseases.

With the patents of numerous biopharmaceutical products expiring by 2016, the market is anticipated to

provide a lucrative opportunity for contract manufacturers operating in the region. Approval of the trail plan

for new drug marketing authorization holder (MAH) in 2016 to produce, conduct clinical trials, and market

the products is expected to provide an impetus to the growth of the industry over the next few years.

Browse Details of Report @ https://www.hexaresearch.com/research-report/china-bioprocess-

instruments-market

Follow Us:

your catalyst to a lucrative business 1

Your Catalyst To a Lucrative Business

Increasing demand for bioprocess instruments in the pharmaceutical, research & development, industrial and

medical laboratories coupled with the increasing number of these facilities is expected to result in the growth

of the market. Change in lifestyle & food consuming habits, and growing levels of air & water pollution have

led to increasing occurrence of disease including obesity which has resulted in a rising number of patients

diagnosed with cancer, heart disease, diabetes and other chronic conditions. Thus, the healthcare sector is

anticipated to create demand for treatment and laboratory services, which will result in the growth of

bioprocess instruments market over the forecast period.

Stringent regulatory policies and the high cost of instruments are likely to restrain the bioprocess instruments

market in China. The government has been focusing on reducing the fragmentation in the industry by

consolidating manufacturers that lack standards in production with larger companies. This move will help in

preventing the quality risks and sub-par manufacturers entering the market. Shortage of skilled labor is

another challenge in the growth of bioprocessing industry.

Koninklijke Philips N.V., Thermo Fisher Scientific Inc. and Becton, Dickinson and Company were the top three

companies in the market in China in 2016. Companies are extensively investing in R&D for innovation and

new product development. In addition, companies are adopting the strategy of merger and acquisition to

expand their product portfolio.

Hexa Research has segmented the China bioprocess instruments market based on type:

Segmentation by type, 2014 - 2024 (USD Million)

• Cell Expansion

• Flow Cytometry

• Biologics Safety Testing

• Cell Line Development

• Tangential Flow Filtration

• Cell Counters

• Virus Filtration

• Cell Culture

• Pyrogen Testing

• Single-Use Bioprocessing

Follow Us:

your catalyst to a lucrative business 2

Your Catalyst To a Lucrative Business

Related Category Market Reports @

Doxorubicin Market -Doxorubicin is an anti-cancer chemotherapy drug. It is an intravenous injection through

a central or peripheral venous line. No pill form of this drug is available in the market.

Antidiabetic Drug Market - Global antidiabetic drug market is expected to witness substantial growth over

the forecast period on account of increasing occurrence of diabetes

Table of Content of China Bioprocess Instruments Market

Chapter 1 Market Summary

1.1 Market trends & movement

Chapter 2 Bioprocess Instruments Market Trends: Drivers & Opportunities

2.1 Introduction

2.2 Key industry trends

2.3 Market driver analysis

2.3.1 Rising prevalence of chronic diseases

2.3.2 Growth in R&D activities in biopharmaceutical industry and life sciences

2.3.3 Market restraint

2.3.4 Stringent regulatory policies

2.4 Value chain analysis

2.5 SWOT

2.6 Porter’s Five Forces’ analysis

Chapter 3 Bioprocess Instruments Market, By Type

3.1 Bioprocess instruments market movement, by type, 2016 & 2024

3.2 Cell Expansion

3.2.1 Market estimates and forecast, 2014 - 2024 (USD Million)

3.3 Flow Cytometry

3.3.1 Market estimates and forecast, 2014 - 2024 (USD Million)

3.4 Biological Safety Testing

3.4.1 Market estimates and forecast, 2014 - 2024 (USD Million)

3.5 Cell Line Development

3.5.1 Market estimates and forecast, 2014 - 2024 (USD Million)

3.6 Tangential Flow Filtration

Follow Us:

your catalyst to a lucrative business 3

Your Catalyst To a Lucrative Business

3.6.1 Market estimates and forecast, 2014 - 2024 (USD Million)

3.7 Cell Counter

3.7.1 Market estimates and forecast, 2014 - 2024 (USD Million)

3.8 Cell Culture

3.8.1 Market estimates and forecast, 2014 - 2024 (USD Million)

3.9 Pyrogen Testing

3.9.1 Market estimates and forecast, 2014 - 2024 (USD Million)

3.10 Single Use Bioprocessing

3.10.1 Market estimates and forecast, 2014 - 2024 (USD Million)

3.11 Virus Filtration

3.11.1 Market estimates and forecast, 2014 - 2024 (USD Million)

Chapter 4 Competitive Landscape

4.1 Competitive landscape analysis, 2016

4.2 Strategic framework

4.3 Potential customer base

4.4 Company market positioning

4.5 Company profiles

4.5.1 Abbott

4.5.1.1 Company Overview

4.5.1.2 Financial performance

4.5.1.3 Product benchmarking

4.5.1.4 Recent Initiatives

4.5.2 Thermo Fisher Scientific Inc.

4.5.2.1 Company Overview

4.5.2.2 Product benchmarking

4.5.2.3 Financial performance

4.5.2.4 Recent Initiatives

4.5.3 Alere Inc.

4.5.3.1 Company overview

4.5.3.2 Product benchmarking

4.5.3.3 Financial performance

4.5.3.4 Recent Initiatives

4.5.4 Becton, Dickinson and Company (BD)

4.5.4.1 Company Overview

4.5.4.2 Product benchmarking

4.5.4.3 Financial performance

Follow Us:

your catalyst to a lucrative business 4

Your Catalyst To a Lucrative Business

4.5.4.4 Recent Initiatives

4.5.5 Koninklijke Philips N.V.

4.5.5.1 Company Overview

4.5.5.2 Product benchmarking

4.5.5.3 Financial performance

4.5.5.4 Recent Initiatives

4.5.6 PerkinElmer, Inc.

4.5.6.1 Company overview

4.5.6.2 Financial performance

4.5.6.3 Product benchmarking

4.5.6.4 Recent Initiatives

4.5.7 Danaher

4.5.7.1 Company Overview

4.5.7.2 Financial performance

4.5.7.3 Recent Initiatives

4.5.8 SHIMADZU CORPORATION

4.5.8.1 Company overview

4.5.8.2 Financial performance

4.5.8.3 Product benchmarking

4.5.8.4 Recent Initiatives

4.5.9 CESCO BIOENGINEERING CO., LTD

4.5.9.1 Company overview

4.5.9.2 Product benchmarking

4.5.10 Shanghai RITAI medicine equipment project co., ltd

4.5.10.1 Company overview

4.5.10.2 Product benchmarking

4.6 List of Other Vendors

Chapter 5 Methodology and Scope

5.1 Research Methodology

5.2 Research Scope & Assumptions

5.3 List of Data Sources

Follow Us:

your catalyst to a lucrative business 5

Your Catalyst To a Lucrative Business

About Us:

Hexa Research is a market research and consulting organization, offering industry reports, custom research

and consulting services to a host of key industries across the globe. We offer comprehensive business

intelligence in the form of industry reports which help our clients obtain clarity about their business

environment and enable them to undertake strategic growth initiatives.

Contact Us:

Ryan Shaw

Hexa Research

Felton Office Plaza

6265 Highway 9

Felton, California 95018

United States

Phone: +1-800-489-3075

Email: sales@hexaresearch.com

Website - http://www.hexaresearch.com/

Follow Us: